C07D 473/04
Two oxygen atoms
Official title: two oxygen atoms
C07D473/04 (Two oxygen atoms) appears on 759 US grants and 612 published applications in this corpus.
Search patents in C07D- Granted patents
- 759
- Published applications
- 612
- Assignees
- 428
- Inventors
- 2,035
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 7 | 0 |
| 1978 | 10 | 0 |
| 1979 | 5 | 0 |
| 1980 | 10 | 0 |
| 1981 | 12 | 0 |
| 1982 | 7 | 0 |
| 1983 | 19 | 0 |
| 1984 | 13 | 0 |
| 1985 | 21 | 0 |
| 1986 | 16 | 0 |
| 1987 | 12 | 0 |
| 1988 | 14 | 0 |
| 1989 | 17 | 0 |
| 1990 | 11 | 0 |
| 1991 | 18 | 0 |
| 1992 | 17 | 0 |
| 1993 | 8 | 0 |
| 1994 | 19 | 0 |
| 1995 | 17 | 0 |
| 1996 | 15 | 0 |
| 1997 | 21 | 0 |
| 1998 | 32 | 0 |
| 1999 | 16 | 0 |
| 2000 | 15 | 0 |
| 2001 | 17 | 0 |
| 2002 | 13 | 14 |
| 2003 | 13 | 27 |
| 2004 | 14 | 33 |
| 2005 | 9 | 29 |
| 2006 | 16 | 26 |
| 2007 | 15 | 28 |
| 2008 | 10 | 23 |
| 2009 | 23 | 24 |
| 2010 | 19 | 37 |
| 2011 | 11 | 32 |
| 2012 | 23 | 26 |
| 2013 | 17 | 31 |
| 2014 | 14 | 33 |
| 2015 | 28 | 39 |
| 2016 | 32 | 23 |
| 2017 | 19 | 26 |
| 2018 | 10 | 23 |
| 2019 | 25 | 20 |
| 2020 | 15 | 22 |
| 2021 | 18 | 21 |
| 2022 | 11 | 16 |
| 2023 | 5 | 17 |
| 2024 | 7 | 18 |
| 2025 | 10 | 7 |
| 2026 | 6 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tetrahydrococannabinolic acid cocrystals11 Aug 2026US 12,702,675 B2Manoira Corporation
- Solid state forms of Resmetirom5 May 2026US 12,616,701 B2Assia Chemical Industries Ltd.
- Purine compounds for treating disorders10 Mar 2026US 12,570,656 B2Marvel Biotechnology
- Small molecules against cereblon to enhance effector T cell function3 Mar 2026US 12,564,583 B2Lee Moffitt Cancer Center and Research Institute, Inc.
- Purine diones as Wnt pathway modulators24 Feb 2026US 12,559,495 B2Agency for Science, Technology and Research
- Pyrazolopyrimidine derivatives as inhibitors of nlrp31 Oct 2026US 2026/0297092 A1Takeda Pharmaceutical Company Limited
- Crystalline complexes between velagliflozin and selected co-crystal forming agents, methods for their preparation and the use thereof for preparing medicaments24 Sep 2026US 2026/0285825 A1Boehringer Ingelheim Vetmedica GmbH
- Purine derivatives as drugs for the treatment of neonatal hypoxia-ischemia brain injury and related diseases20 Aug 2026US 2026/0240857 A1Commissariat A L' Energie Atomique Et Aux Energies Alternatives
- Intermolecular cyclopropanation of unsaturated hydrocarbons20 Aug 2026US 2026/0242327 A1The Penn State Research Foundation
- Solid state forms of resmetirom13 Aug 2026US 2026/0232680 A1Assia Chemical Industries Ltd.
Most cited
By later US patents
- Methods and compositions for treating viral infections and guanine acyclic nucleosides135US 4,199,574 ABurroughs Wellcome Co. · 1980
- Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists123US 5,332,744 AMerck & Co., Inc. · 1994
- 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions122US 7,407,955 B2Boehringer Ingelheim Pharma GMBH & CO.KG · 2008
- Electrochemiluminescent rhenium moieties and methods for their use120US 5,591,581 AIgen, Inc. · 1997
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001